Fluorofenidone offers improved renoprotection at early interventions during the course of diabetic nephropathy in db/db mice via multiple pathways.

导出 OA

翻译打印收藏纠错

作者： Xuan,Xiong ^[1] ; Wenjuan,Mei ^[1] ; Yanyun,Xie ^[2] ; Jishi,Liu ^[3] ; Miaomiao,Lu ^[1] ; Xiongqun,Peng ^[4] ; Congyin,Yang ^[4] ; Xin,Zhang ^[4] ; Mingyan,Xie ^[4] ; Renna,Luo ^[1] ; Xiangning,Yuan ^[1] ; Ling,Huang ^[1] ; Lin,Wu ^[1] ; Jiao,Qin ^[1] ; Yu,Peng ^[1] ; Xiujie,Jia ^[5] ; Gaoyun,Hu ^[6] ; Damu,Tang ^[7] ; Lijian,Tao ^[8]

作者单位： Division of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China. ^[1] Division of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. ^[2] Department of Nephrology, The Third Xiangya Hospital, Changsha, Hunan, China. ^[3] Department of Gastroenterology, Xiangya Hospital, Changsha, Hunan, China. ^[4] Department of Respiratory Medicine, The second Xiangya Hospital, Changsha, Hunan, China. ^[5] Chemistry Section, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China. ^[6] Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. ^[7] Division of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China; State Key Laboratory of Medical Genetics of China, Central South University, Changsha, Hunan, China. ^[8]